Nanobiotix (NBTX) Total Debt: 2019-2025

  • Nanobiotix's Total Debt rose 9.54% to $58.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $217.9 million, marking a year-over-year decrease of 1.39%. This contributed to the annual value of $54.4 million for FY2024, which is 0.55% down from last year.
  • Latest data reveals that Nanobiotix reported Total Debt of $58.0 million as of Q2 2025, which was up 6.63% from $54.4 million recorded in Q4 2024.
  • Over the past 5 years, Nanobiotix's Total Debt peaked at $61.1 million during Q2 2021, and registered a low of $48.1 million during Q2 2022.
  • Over the past 3 years, Nanobiotix's median Total Debt value was $54.4 million (recorded in 2023), while the average stood at $55.7 million.
  • As far as peak fluctuations go, Nanobiotix's Total Debt fell by 21.20% in 2022, and later rose by 22.17% in 2023.
  • Quarterly analysis of 5 years shows Nanobiotix's Total Debt stood at $52.6 million in 2021, then declined by 21.20% to $48.1 million in 2022, then rose by 22.17% to $54.4 million in 2023, then declined by 0.02% to $54.4 million in 2024, then rose by 9.54% to $58.0 million in 2025.
  • Its Total Debt was $58.0 million in Q2 2025, compared to $54.4 million in Q4 2024 and $52.9 million in Q2 2024.